| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stanley Tennant last filed a Form 4 in June 2018, as Director at CRDF. Stanley Tennant's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 236,061 shares of CRDF. Net of sales, the CRDF filings show accumulation of 36,632 shares.
Stanley Tennant has 12 Form 4 filings on record from March 2015 to June 2018, all as Director at Cardiff Oncology (CRDF), 2015–2018.
The 12 reported transactions were 5 option or other derivative awards, 4 open-market purchases, 2 option exercises and 1 open-market sale.
Counted by filing, the open-market trades come to 4 purchases worth about $120K and 1 sale worth about $6K.
The largest open-market purchase was 10,000 shares of CRDF at an average $6.06 on August 12, 2015, about $61K.
The only open-market sale was 8,334 shares of CRDF at an average $0.69 on September 5, 2017, about $6K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2018 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $0.80 | $8,000.00 | +4.4% | |
| Sep 5, 2017 | CRDF Cardiff Oncology, Inc. | Director | Sell | 8,334 | $0.69 | $5,750.46 | -3.8% | |
| Dec 19, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $2.10 | $21,000.00 | +4.8% | |
| Dec 16, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 14,966 | $2.00 | $29,932.00 | +7.8% | |
| Aug 12, 2015 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $6.06 | $60,600.00 | +5.5% |